Adding molecular cancer insight to aging and prevention programs.
Longevity clinics help clients extend their health span by combining advanced diagnostics, biomarkers, and lifestyle interventions. While genetic testing and biological age tracking are powerful tools, many clients also want to know what’s happening in their body right now.
The miRoncol Real-time Multi-Cancer Early Risk Assessment provides that perspective: a blood-based, real-time molecular snapshot of cancer-associated signals that complements existing longevity and wellness programs.
Why It Matters for Longevity Care
- Cancer is one of the greatest barriers to healthy aging, responsible for nearly half of all deaths in Canadians over 65.
- Standard screenings only cover a few cancers and are limited by eligibility.
- Molecular signals like microRNAs in blood can reveal early changes long before symptoms or imaging.
How It Fits Into Longevity Programs
Annual assessments
Add molecular risk testing alongside biological age and metabolic health markers.
Longitudinal monitoring
Track how molecular signals evolve with age, lifestyle, or interventions.
Personalized prevention
Provide clients with a more complete view of their health today, not just their genetic predisposition.
Scientific Foundation
- Studied using 11,000+ human samples across 12+ solid tumour types
- Specificity above 99%, with high sensitivity for many cancers
- Published in Cancers (2022) and Scientific Reports (2024)
- Nobel recognition for the discovery of microRNAs (2024)
Benefits for Longevity Clinics
- Adds a molecular dimension to cancer tracking
- Complements biological age, genetics, and functional health measures
- Offers clients peace of mind and clarity about real-time cancer risk
- Strengthens your clinic’s position as a leader in preventive longevity care
- Helps give clients the best chance to survive and thrive by supporting earlier detection and better
Limitations & Ethics
The test is an early risk assessment, not diagnostic. Results must always be reviewed with a physician and are designed to complement, not replace, conventional screening.
Next Step
By integrating miRoncol’s Real-time Multi-Cancer Early Risk Assessment, longevity clinics can expand their preventive offerings and give clients meaningful insight into cancer risk — today and over time.
